跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pamorelin Powder for Suspension for Injection 11.25 mg per vial - HSA Drug Approval Details
Approvals
/
HSA
/
Pamorelin Powder for Suspension for Injection 11.25 mg per vial
Approved
STANDARD
Pamorelin Powder for Suspension for Injection 11.25 mg per vial
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
dd61a2b6b0c2f302
Company
Unknown
Type
Standard
Approval Details
Approval Id
dd61a2b6b0c2f302
Drug Name
Pamorelin Powder for Suspension for Injection 11.25 mg per vial
Active Ingredients
Triptorelin Embonate 16.8 mg eqv Triptorelin
11.25 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
dd61a2b6b0c2f302
Type
Standard
Back to HSA Approvals
